Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon

Abstract Chagas disease (CD), with approximately 10,000 deaths annually, has become a worldwide health problem. Approximately 35% of cases may show cardiac manifestations such as arrhythmias and/or conduction disorders, heart failure, thromboembolic accidents, and sudden death. The Amazon region has...

Full description

Bibliographic Details
Published in:Revista da Sociedade Brasileira de Medicina Tropical
Main Authors: Katia do Nascimento Couceiro, Jessica Vanina Ortiz, Mônica Regina Hosannah da Silva e Silva, Débora Raysa Teixeira de Sousa, Kenny Rodrigues de Souza, Gabriela Maciel Alencar, Laylah Kelre Costa Magalhães, Maria das Graças Vale Barbosa Guerra, João Marcos Bemfica Barbosa Ferreira, Jorge Augusto de Oliveira Guerra
Format: Article in Journal/Newspaper
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2021
Subjects:
Online Access:https://doi.org/10.1590/0037-8682-0480-2020
https://doaj.org/article/26f25674e3a444dc9c62f841154f3f15
Description
Summary:Abstract Chagas disease (CD), with approximately 10,000 deaths annually, has become a worldwide health problem. Approximately 35% of cases may show cardiac manifestations such as arrhythmias and/or conduction disorders, heart failure, thromboembolic accidents, and sudden death. The Amazon region has long been considered a non-endemic area for CD; however, in the last decades, with an increase in the number of acute and chronic cases, disease evolution has received greater attention. Here, we report the successful implementation of a cardioverter-defibrillator for the prevention of sudden death in a patient with autochthonous Chagas cardiomyopathy in the Brazilian Amazon.